Discover
LVTX
LAVA Therapeutics N.V.
1.74
2 x 1.31
2 x 2.08
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 82.97% | |
| 1y | 8.75% |
1.74
day range
1.74
0.96
52 week range
6.47
| Open | 1.81 | Prev Close | 1.74 | Low | 1.74 | High | 1.74 | Mkt Cap | 25.87M |
| Vol | 173.18K | Avg Vol | 89.05K | EPS | -1.01 | P/E | N/A | Forward P/E | -0.51 |
| Beta | 0.48 | Short Ratio | 0.41 | Inst. Own | 31.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.63 | 200-d Avg | 2.12 | 1yr Est | 2.32 |
| Income Statement | |||
| Operating Expenses | 7.55M | ||
| Research and Development Expense | 2.24M | ||
| Selling, General and Administrative Expense | 5.31M | ||
| Operating Income | -7.55M | ||
| Income Tax Expense | 6.00K | ||
| Net Income | -7.19M | ||
| Net Income Common Stock | -7.19M | ||
| Net Income Common Stock (USD) | -8.46M | ||
| Consolidated Income | -7.19M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -7.18M | ||
| Earning Before Interest & Taxes (USD) | -8.45M | ||
| Weighted Average Shares | 26.90M | ||
| Weighted Average Shares Diluted | 26.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.66M | ||
| Cash and Equivalents (USD) | 58.43M | ||
| Current Assets | 51.91M | ||
| Total Assets | 51.92M | ||
| Current Liabilities | 4.23M | ||
| Total Liabilities | 39.23M | ||
| Accumulated Retained Earnings (Deficit) | -194.28M | ||
| Accumulated Other Comprehensive Income | -9.78M | ||
| Shareholders Equity | 12.68M | ||
| Shareholders Equity (USD) | 14.92M | ||
| Assets Non-Current | 10.00K | ||
| Deferred Revenue | 35.00M | ||
| Liabilities Non-Current | 35.00M | ||
| Trade and Non-Trade Payables | 1.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 22.83M | ||
| Capital Expenditure | 5.00K | ||
| Net Cash Flow from Investing | 27.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.70M | ||
| Net Cash Flow from Operations | -4.87M | ||
| Effect of Exchange Rate Changes on Cash | 450.00K | ||
| Share Based Compensation | 393.00K | ||